Review



primary antibodies against proliferating cell nuclear antigen (pcna)  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher primary antibodies against proliferating cell nuclear antigen (pcna)
    Ox-LDL induces HVSMC injury. HVSMCs were treated with various concentrations of ox-LDL (0, 25, 50, and 100 µg/mL), and cell viability was analyzed by CCK-8 (a), cell proliferation by EdU assay (b), cell invasion by transwell assay (c), cell migration by wound-healing assay (d and e), and the protein expression of <t>PCNA</t> <t>and</t> <t>MMP2</t> by Western blotting analysis (f). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
    Primary Antibodies Against Proliferating Cell Nuclear Antigen (Pcna), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against proliferating cell nuclear antigen (pcna)/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    primary antibodies against proliferating cell nuclear antigen (pcna) - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway"

    Article Title: Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway

    Journal: Open Medicine

    doi: 10.1515/med-2023-0687

    Ox-LDL induces HVSMC injury. HVSMCs were treated with various concentrations of ox-LDL (0, 25, 50, and 100 µg/mL), and cell viability was analyzed by CCK-8 (a), cell proliferation by EdU assay (b), cell invasion by transwell assay (c), cell migration by wound-healing assay (d and e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
    Figure Legend Snippet: Ox-LDL induces HVSMC injury. HVSMCs were treated with various concentrations of ox-LDL (0, 25, 50, and 100 µg/mL), and cell viability was analyzed by CCK-8 (a), cell proliferation by EdU assay (b), cell invasion by transwell assay (c), cell migration by wound-healing assay (d and e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Techniques Used: CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Expressing, Western Blot

    The effects of circ_0113656 on ox-LDL-induced HVSMC injury. (a) Circ_0113656 expression was detected by qRT-PCR in the blood samples of AS patients and healthy volunteers ( N = 17 and N = 13, respectively). (b) Circ_0113656 expression was detected by qRT-PCR in HVSMCs treated with ox-LDL (0, 25, 50, and 100 µg/mL). (c and d) The circular structure of circ_0113656 was identified by using RNase R, random primers, and oligo(dT) 18 primers. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, and ox-LDL + si-circ_0113656 group, with untreated HVSMCs as controls, and circ_0113656 expression was analyzed by qRT-PCR (e), cell viability by CCK-8 (f), cell proliferation by EdU assay (g), cell invasion by transwell assay (h), cell migration by wound-healing assay (i), and the protein expression of PCNA and MMP2 by Western blotting analysis (j). ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
    Figure Legend Snippet: The effects of circ_0113656 on ox-LDL-induced HVSMC injury. (a) Circ_0113656 expression was detected by qRT-PCR in the blood samples of AS patients and healthy volunteers ( N = 17 and N = 13, respectively). (b) Circ_0113656 expression was detected by qRT-PCR in HVSMCs treated with ox-LDL (0, 25, 50, and 100 µg/mL). (c and d) The circular structure of circ_0113656 was identified by using RNase R, random primers, and oligo(dT) 18 primers. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, and ox-LDL + si-circ_0113656 group, with untreated HVSMCs as controls, and circ_0113656 expression was analyzed by qRT-PCR (e), cell viability by CCK-8 (f), cell proliferation by EdU assay (g), cell invasion by transwell assay (h), cell migration by wound-healing assay (i), and the protein expression of PCNA and MMP2 by Western blotting analysis (j). ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Techniques Used: Expressing, Quantitative RT-PCR, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Western Blot

    The effects of circ_0113656 knockdown and miR-188-3p depletion on ox-LDL-induced HVSMC injury. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, ox-LDL + si-circ_0113656 group, ox-LDL + si-circ_0113656 + anti-miR-NC group, and ox-LDL + si-circ_0113656 + anti-miR-188-3p group, with untreated HVSMCs as controls. MiR-188-3p expression was analyzed by qRT-PCR (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
    Figure Legend Snippet: The effects of circ_0113656 knockdown and miR-188-3p depletion on ox-LDL-induced HVSMC injury. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, ox-LDL + si-circ_0113656 group, ox-LDL + si-circ_0113656 + anti-miR-NC group, and ox-LDL + si-circ_0113656 + anti-miR-188-3p group, with untreated HVSMCs as controls. MiR-188-3p expression was analyzed by qRT-PCR (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Techniques Used: Knockdown, Expressing, Quantitative RT-PCR, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Western Blot

    The effects of miR-188-3p and IGF2 on ox-LDL-induced HVSMC disorders. HVSMCs were divided into the ox-LDL group, ox-LDL + miR-NC group, ox-LDL + miR-188-3p group, ox-LDL + miR-188-3p + pcDNA group, and ox-LDL + miR-188-3p + IGF2 group, with mock HVSMCs as controls. IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
    Figure Legend Snippet: The effects of miR-188-3p and IGF2 on ox-LDL-induced HVSMC disorders. HVSMCs were divided into the ox-LDL group, ox-LDL + miR-NC group, ox-LDL + miR-188-3p group, ox-LDL + miR-188-3p + pcDNA group, and ox-LDL + miR-188-3p + IGF2 group, with mock HVSMCs as controls. IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Techniques Used: Expressing, Western Blot, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay

    The effects of IGF2 overexpression on HVSMC phenotypes. HVSMCs were transfected with pcDNA or the overexpression plasmid of IGF2, and IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d), cell migration by wound-healing assay (e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). ** P < 0.01, and *** P < 0.001.
    Figure Legend Snippet: The effects of IGF2 overexpression on HVSMC phenotypes. HVSMCs were transfected with pcDNA or the overexpression plasmid of IGF2, and IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d), cell migration by wound-healing assay (e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). ** P < 0.01, and *** P < 0.001.

    Techniques Used: Over Expression, Transfection, Plasmid Preparation, Expressing, Western Blot, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay



    Similar Products

    90
    Cell Signaling Technology Inc primary antibodies against proliferation cell nuclear antigen pcna
    Primary Antibodies Against Proliferation Cell Nuclear Antigen Pcna, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against proliferation cell nuclear antigen pcna/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against proliferation cell nuclear antigen pcna - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibody against proliferating cell nuclear antigen (pcna)
    Primary Antibody Against Proliferating Cell Nuclear Antigen (Pcna), supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against proliferating cell nuclear antigen (pcna)/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibody against proliferating cell nuclear antigen (pcna) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Wanleibio primary antibody against proliferating cell nuclear antigen (pcna; wl02208)
    Primary Antibody Against Proliferating Cell Nuclear Antigen (Pcna; Wl02208), supplied by Wanleibio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against proliferating cell nuclear antigen (pcna; wl02208)/product/Wanleibio
    Average 90 stars, based on 1 article reviews
    primary antibody against proliferating cell nuclear antigen (pcna; wl02208) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    GeneTex primary antibodies against proliferating cell nuclear antigen (pcna)
    Primary Antibodies Against Proliferating Cell Nuclear Antigen (Pcna), supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against proliferating cell nuclear antigen (pcna)/product/GeneTex
    Average 90 stars, based on 1 article reviews
    primary antibodies against proliferating cell nuclear antigen (pcna) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Abmart Inc primary antibodies against proliferating cell nuclear antigen (pcna)
    Primary Antibodies Against Proliferating Cell Nuclear Antigen (Pcna), supplied by Abmart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against proliferating cell nuclear antigen (pcna)/product/Abmart Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against proliferating cell nuclear antigen (pcna) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    ZenBio rabbit anti- human primary antibodies against proliferating cell nuclear antigen (pcna)
    Rabbit Anti Human Primary Antibodies Against Proliferating Cell Nuclear Antigen (Pcna), supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti- human primary antibodies against proliferating cell nuclear antigen (pcna)/product/ZenBio
    Average 90 stars, based on 1 article reviews
    rabbit anti- human primary antibodies against proliferating cell nuclear antigen (pcna) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher primary antibodies against proliferating cell nuclear antigen (pcna)
    Ox-LDL induces HVSMC injury. HVSMCs were treated with various concentrations of ox-LDL (0, 25, 50, and 100 µg/mL), and cell viability was analyzed by CCK-8 (a), cell proliferation by EdU assay (b), cell invasion by transwell assay (c), cell migration by wound-healing assay (d and e), and the protein expression of <t>PCNA</t> <t>and</t> <t>MMP2</t> by Western blotting analysis (f). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
    Primary Antibodies Against Proliferating Cell Nuclear Antigen (Pcna), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against proliferating cell nuclear antigen (pcna)/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    primary antibodies against proliferating cell nuclear antigen (pcna) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    ABclonal Biotechnology primary antibodies against proliferating cell nuclear antigen (pcna)
    Here, Zfp521 promoted chondrocyte proliferation and inhibited apoptosis. (a) The EdU staining for the Zfp521-siRNA and vehicle siRNA chondrocytes was performed. Scale bar: 200 μm. (b) Comparison of the TUNEL staining for the Zfp521-siRNA and vehicle siRNA chondrocytes. Scale bar: 200 μm. (c-d) Quantitative analysis of the EdU and TUNEL assays between the Zfp521-siRNA group and vehicle siRNA group. (e–f) Immunohistochemical staining for <t>PCNA</t> <t>and</t> <t>caspase-3</t> in the ACLT rats at nine weeks postop. Black scale bar: 50 μm. Blue scale bar: 15 μm. (g–h) Quantitative analysis of the immunohistochemical staining for PCNA and caspase-3 in the ACLT rats. **P < 0.01 and ***P < 0.001. ns: not significant.
    Primary Antibodies Against Proliferating Cell Nuclear Antigen (Pcna), supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against proliferating cell nuclear antigen (pcna)/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies against proliferating cell nuclear antigen (pcna) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against proliferating cell nuclear antigen (pcna
    Here, Zfp521 promoted chondrocyte proliferation and inhibited apoptosis. (a) The EdU staining for the Zfp521-siRNA and vehicle siRNA chondrocytes was performed. Scale bar: 200 μm. (b) Comparison of the TUNEL staining for the Zfp521-siRNA and vehicle siRNA chondrocytes. Scale bar: 200 μm. (c-d) Quantitative analysis of the EdU and TUNEL assays between the Zfp521-siRNA group and vehicle siRNA group. (e–f) Immunohistochemical staining for <t>PCNA</t> <t>and</t> <t>caspase-3</t> in the ACLT rats at nine weeks postop. Black scale bar: 50 μm. Blue scale bar: 15 μm. (g–h) Quantitative analysis of the immunohistochemical staining for PCNA and caspase-3 in the ACLT rats. **P < 0.01 and ***P < 0.001. ns: not significant.
    Primary Antibodies Against Proliferating Cell Nuclear Antigen (Pcna, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against proliferating cell nuclear antigen (pcna/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against proliferating cell nuclear antigen (pcna - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Ox-LDL induces HVSMC injury. HVSMCs were treated with various concentrations of ox-LDL (0, 25, 50, and 100 µg/mL), and cell viability was analyzed by CCK-8 (a), cell proliferation by EdU assay (b), cell invasion by transwell assay (c), cell migration by wound-healing assay (d and e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Journal: Open Medicine

    Article Title: Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway

    doi: 10.1515/med-2023-0687

    Figure Lengend Snippet: Ox-LDL induces HVSMC injury. HVSMCs were treated with various concentrations of ox-LDL (0, 25, 50, and 100 µg/mL), and cell viability was analyzed by CCK-8 (a), cell proliferation by EdU assay (b), cell invasion by transwell assay (c), cell migration by wound-healing assay (d and e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Article Snippet: After blocking the aspecific signals using skimmed milk (Yili, Beijing, China), polyvinylidene fluoride membranes with protein bands were incubated with the primary antibodies against proliferating cell nuclear antigen (PCNA) (#13-3900; 1:5000; Thermo Fisher, Waltham, MA, USA), matrix metalloprotein 2 (MMP2) (#436000; 1:250; Thermo Fisher), IGF2 (#MA5-17096; 1:1,000; Thermo Fisher), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (#MA1-16757; 1:2,000; Thermo Fisher).

    Techniques: CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Expressing, Western Blot

    The effects of circ_0113656 on ox-LDL-induced HVSMC injury. (a) Circ_0113656 expression was detected by qRT-PCR in the blood samples of AS patients and healthy volunteers ( N = 17 and N = 13, respectively). (b) Circ_0113656 expression was detected by qRT-PCR in HVSMCs treated with ox-LDL (0, 25, 50, and 100 µg/mL). (c and d) The circular structure of circ_0113656 was identified by using RNase R, random primers, and oligo(dT) 18 primers. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, and ox-LDL + si-circ_0113656 group, with untreated HVSMCs as controls, and circ_0113656 expression was analyzed by qRT-PCR (e), cell viability by CCK-8 (f), cell proliferation by EdU assay (g), cell invasion by transwell assay (h), cell migration by wound-healing assay (i), and the protein expression of PCNA and MMP2 by Western blotting analysis (j). ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Journal: Open Medicine

    Article Title: Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway

    doi: 10.1515/med-2023-0687

    Figure Lengend Snippet: The effects of circ_0113656 on ox-LDL-induced HVSMC injury. (a) Circ_0113656 expression was detected by qRT-PCR in the blood samples of AS patients and healthy volunteers ( N = 17 and N = 13, respectively). (b) Circ_0113656 expression was detected by qRT-PCR in HVSMCs treated with ox-LDL (0, 25, 50, and 100 µg/mL). (c and d) The circular structure of circ_0113656 was identified by using RNase R, random primers, and oligo(dT) 18 primers. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, and ox-LDL + si-circ_0113656 group, with untreated HVSMCs as controls, and circ_0113656 expression was analyzed by qRT-PCR (e), cell viability by CCK-8 (f), cell proliferation by EdU assay (g), cell invasion by transwell assay (h), cell migration by wound-healing assay (i), and the protein expression of PCNA and MMP2 by Western blotting analysis (j). ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Article Snippet: After blocking the aspecific signals using skimmed milk (Yili, Beijing, China), polyvinylidene fluoride membranes with protein bands were incubated with the primary antibodies against proliferating cell nuclear antigen (PCNA) (#13-3900; 1:5000; Thermo Fisher, Waltham, MA, USA), matrix metalloprotein 2 (MMP2) (#436000; 1:250; Thermo Fisher), IGF2 (#MA5-17096; 1:1,000; Thermo Fisher), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (#MA1-16757; 1:2,000; Thermo Fisher).

    Techniques: Expressing, Quantitative RT-PCR, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Western Blot

    The effects of circ_0113656 knockdown and miR-188-3p depletion on ox-LDL-induced HVSMC injury. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, ox-LDL + si-circ_0113656 group, ox-LDL + si-circ_0113656 + anti-miR-NC group, and ox-LDL + si-circ_0113656 + anti-miR-188-3p group, with untreated HVSMCs as controls. MiR-188-3p expression was analyzed by qRT-PCR (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Journal: Open Medicine

    Article Title: Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway

    doi: 10.1515/med-2023-0687

    Figure Lengend Snippet: The effects of circ_0113656 knockdown and miR-188-3p depletion on ox-LDL-induced HVSMC injury. HVSMCs were divided into the ox-LDL group, ox-LDL + si-NC group, ox-LDL + si-circ_0113656 group, ox-LDL + si-circ_0113656 + anti-miR-NC group, and ox-LDL + si-circ_0113656 + anti-miR-188-3p group, with untreated HVSMCs as controls. MiR-188-3p expression was analyzed by qRT-PCR (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Article Snippet: After blocking the aspecific signals using skimmed milk (Yili, Beijing, China), polyvinylidene fluoride membranes with protein bands were incubated with the primary antibodies against proliferating cell nuclear antigen (PCNA) (#13-3900; 1:5000; Thermo Fisher, Waltham, MA, USA), matrix metalloprotein 2 (MMP2) (#436000; 1:250; Thermo Fisher), IGF2 (#MA5-17096; 1:1,000; Thermo Fisher), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (#MA1-16757; 1:2,000; Thermo Fisher).

    Techniques: Knockdown, Expressing, Quantitative RT-PCR, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay, Western Blot

    The effects of miR-188-3p and IGF2 on ox-LDL-induced HVSMC disorders. HVSMCs were divided into the ox-LDL group, ox-LDL + miR-NC group, ox-LDL + miR-188-3p group, ox-LDL + miR-188-3p + pcDNA group, and ox-LDL + miR-188-3p + IGF2 group, with mock HVSMCs as controls. IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Journal: Open Medicine

    Article Title: Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway

    doi: 10.1515/med-2023-0687

    Figure Lengend Snippet: The effects of miR-188-3p and IGF2 on ox-LDL-induced HVSMC disorders. HVSMCs were divided into the ox-LDL group, ox-LDL + miR-NC group, ox-LDL + miR-188-3p group, ox-LDL + miR-188-3p + pcDNA group, and ox-LDL + miR-188-3p + IGF2 group, with mock HVSMCs as controls. IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d and e), cell migration by wound-healing assay (f), and the protein expression of PCNA and MMP2 by Western blotting analysis (g). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Article Snippet: After blocking the aspecific signals using skimmed milk (Yili, Beijing, China), polyvinylidene fluoride membranes with protein bands were incubated with the primary antibodies against proliferating cell nuclear antigen (PCNA) (#13-3900; 1:5000; Thermo Fisher, Waltham, MA, USA), matrix metalloprotein 2 (MMP2) (#436000; 1:250; Thermo Fisher), IGF2 (#MA5-17096; 1:1,000; Thermo Fisher), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (#MA1-16757; 1:2,000; Thermo Fisher).

    Techniques: Expressing, Western Blot, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay

    The effects of IGF2 overexpression on HVSMC phenotypes. HVSMCs were transfected with pcDNA or the overexpression plasmid of IGF2, and IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d), cell migration by wound-healing assay (e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). ** P < 0.01, and *** P < 0.001.

    Journal: Open Medicine

    Article Title: Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway

    doi: 10.1515/med-2023-0687

    Figure Lengend Snippet: The effects of IGF2 overexpression on HVSMC phenotypes. HVSMCs were transfected with pcDNA or the overexpression plasmid of IGF2, and IGF2 expression was analyzed by Western blotting analysis (a), cell viability by CCK-8 (b), cell proliferation by EdU assay (c), cell invasion by transwell assay (d), cell migration by wound-healing assay (e), and the protein expression of PCNA and MMP2 by Western blotting analysis (f). ** P < 0.01, and *** P < 0.001.

    Article Snippet: After blocking the aspecific signals using skimmed milk (Yili, Beijing, China), polyvinylidene fluoride membranes with protein bands were incubated with the primary antibodies against proliferating cell nuclear antigen (PCNA) (#13-3900; 1:5000; Thermo Fisher, Waltham, MA, USA), matrix metalloprotein 2 (MMP2) (#436000; 1:250; Thermo Fisher), IGF2 (#MA5-17096; 1:1,000; Thermo Fisher), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (#MA1-16757; 1:2,000; Thermo Fisher).

    Techniques: Over Expression, Transfection, Plasmid Preparation, Expressing, Western Blot, CCK-8 Assay, EdU Assay, Transwell Assay, Migration, Wound Healing Assay

    Here, Zfp521 promoted chondrocyte proliferation and inhibited apoptosis. (a) The EdU staining for the Zfp521-siRNA and vehicle siRNA chondrocytes was performed. Scale bar: 200 μm. (b) Comparison of the TUNEL staining for the Zfp521-siRNA and vehicle siRNA chondrocytes. Scale bar: 200 μm. (c-d) Quantitative analysis of the EdU and TUNEL assays between the Zfp521-siRNA group and vehicle siRNA group. (e–f) Immunohistochemical staining for PCNA and caspase-3 in the ACLT rats at nine weeks postop. Black scale bar: 50 μm. Blue scale bar: 15 μm. (g–h) Quantitative analysis of the immunohistochemical staining for PCNA and caspase-3 in the ACLT rats. **P < 0.01 and ***P < 0.001. ns: not significant.

    Journal: Bioengineered

    Article Title: Zinc finger protein 521 attenuates osteoarthritis via the histone deacetylases 4 in the nucleus

    doi: 10.1080/21655979.2022.2090203

    Figure Lengend Snippet: Here, Zfp521 promoted chondrocyte proliferation and inhibited apoptosis. (a) The EdU staining for the Zfp521-siRNA and vehicle siRNA chondrocytes was performed. Scale bar: 200 μm. (b) Comparison of the TUNEL staining for the Zfp521-siRNA and vehicle siRNA chondrocytes. Scale bar: 200 μm. (c-d) Quantitative analysis of the EdU and TUNEL assays between the Zfp521-siRNA group and vehicle siRNA group. (e–f) Immunohistochemical staining for PCNA and caspase-3 in the ACLT rats at nine weeks postop. Black scale bar: 50 μm. Blue scale bar: 15 μm. (g–h) Quantitative analysis of the immunohistochemical staining for PCNA and caspase-3 in the ACLT rats. **P < 0.01 and ***P < 0.001. ns: not significant.

    Article Snippet: Specific primary antibodies against proliferating cell nuclear antigen (PCNA) (Abclonal, 1:100), caspase-3 (Abclonal, 1:50), Col II (Abcam, 1:200), Col X (Abcam, 1:50), MMP-13 (Bioss, 1:50), SRY-related HMG box 9 (SOX9) (Abclonal, 1:50), and Runx-2 (Abcam, 1:50) were used.

    Techniques: Staining, Comparison, TUNEL Assay, Immunohistochemical staining